This study linked, for the first time, LRRK2 variants with proteins that have support in our PWAS, MR, and PPMI differential protein-level analyses: some previously implicated in PD (GPNMB), and others not (C1QTNF1 and ITGB2). This evidence concerns the gene ITGB2 and Parkinson disease.